WordNet

treat gently or carefully (同)favour
an act of gracious kindness (同)favour
an advantage to the benefit of someone or something; "the outcome was in his favor" (同)favour
a feeling of favorable regard (同)favour
an inclination to approve; "that style is in favor this season" (同)favour
consider as the favorite; "The local team was favored" (同)favour

PrepTutorEJDIC

出典(authority):フリー百科事典『ウィキペディア（Wikipedia）』「2016/01/22 17:30:36」(JST)

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

Oxidation of manganese(II) with ferrate: Stoichiometry, kinetics, products and impact of organic carbon.

Goodwill JE1, Mai X2, Jiang Y2, Reckhow DA2, Tobiason JE2.
Chemosphere.Chemosphere.2016 Sep;159:457-64. doi: 10.1016/j.chemosphere.2016.06.014. Epub 2016 Jun 21.
Manganese is a contaminant of concern for many drinking water utilities, and future regulation may be pending. An analysis of soluble manganese (Mn(II)) oxidation by ferrate (Fe(VI)) was executed at the bench-scale, in a laboratory matrix, both with and without the presence of natural organic matter
PMID 27341149

Consumer trust in the Australian food system - The everyday erosive impact of food labelling.

Tonkin E1, Webb T2, Coveney J3, Meyer SB4, Wilson AM3.
Appetite.Appetite.2016 Aug 1;103:118-27. doi: 10.1016/j.appet.2016.04.004. Epub 2016 Apr 8.
Consumer trust in food system actors is foundational for ensuring consumer confidence in food safety. As food labelling is a direct communication between consumers and food system actors, it may influence consumer perceptions of actor trustworthiness. This study explores the judgements formed about
PMID 27063669

A UK feasibility and validation study of the VE1 monoclonal antibody immunohistochemistry stain for BRAF-V600E mutations in metastatic melanoma.

Lo MC1, Paterson A2, Maraka J1, Clark R1, Goodwill J3, Nobes J4,5, Garioch J5,6, Moncrieff M1,5, Rytina E2, Igali L3,5.
British journal of cancer.Br J Cancer.2016 Jul 12;115(2):223-7. doi: 10.1038/bjc.2016.106. Epub 2016 Jun 23.
BACKGROUND: Determining the BRAF mutation status of patients with advanced metastatic melanoma is essential in order to assess patients' eligibility for targeted BRAF inhibitor therapy. The aim of this study was to validate the utility of immunohistochemistry (IHC) to rapidly obtain the BRAF status
PMID 27336602